| Lisa Stucky-marshall, APN | |
|
177 E Brush Hill Rd, Elmhurst, IL 60126 | |
| (331) 221-2161 | |
| (331) 221-3857 |
| Full Name | Lisa Stucky-marshall |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 33 Years |
| Location | 177 E Brush Hill Rd, Elmhurst, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124073713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SX0200X | Clinical Nurse Specialist - Oncology | 209-002340 (Illinois) | Secondary |
| 363L00000X | Nurse Practitioner | 209002340 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward Health Ventures | 4284531484 | 510 |
News Archive
A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.
Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism. This is the company's first sample to be released and infused for the condition. This release closely coincides with World Autism Awareness Day on the 2nd April, for which Smart Cells have released a simple informational guide on autism for parents.
Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat COVID-19. And while the COVID-19 vaccines represent the best measure to prevent the disease, therapies for those who do get infected remain in short supply.
Diabetes Care published online the results of the Novo Nordisk LEAD™ 6 extension study, which evaluated the efficacy and safety of switching from exenatide, which is taken twice a day, to once-daily Victoza®. Results show that when added to oral antidiabetes drugs, patients who switched from exenatide to Victoza experienced further reductions in A1c and weight loss.
› Verified 7 days ago
| Entity Name | Edward Health Ventures |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452912 PECOS PAC ID: 4284531484 Enrollment ID: O20031216000616 |
News Archive
A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.
Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism. This is the company's first sample to be released and infused for the condition. This release closely coincides with World Autism Awareness Day on the 2nd April, for which Smart Cells have released a simple informational guide on autism for parents.
Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat COVID-19. And while the COVID-19 vaccines represent the best measure to prevent the disease, therapies for those who do get infected remain in short supply.
Diabetes Care published online the results of the Novo Nordisk LEAD™ 6 extension study, which evaluated the efficacy and safety of switching from exenatide, which is taken twice a day, to once-daily Victoza®. Results show that when added to oral antidiabetes drugs, patients who switched from exenatide to Victoza experienced further reductions in A1c and weight loss.
› Verified 7 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.
Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism. This is the company's first sample to be released and infused for the condition. This release closely coincides with World Autism Awareness Day on the 2nd April, for which Smart Cells have released a simple informational guide on autism for parents.
Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat COVID-19. And while the COVID-19 vaccines represent the best measure to prevent the disease, therapies for those who do get infected remain in short supply.
Diabetes Care published online the results of the Novo Nordisk LEAD™ 6 extension study, which evaluated the efficacy and safety of switching from exenatide, which is taken twice a day, to once-daily Victoza®. Results show that when added to oral antidiabetes drugs, patients who switched from exenatide to Victoza experienced further reductions in A1c and weight loss.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Stucky-marshall, APN 177 E Brush Hill Rd, Elmhurst, IL 60126-5658 Ph: (331) 221-2161 | Lisa Stucky-marshall, APN 177 E Brush Hill Rd, Elmhurst, IL 60126 Ph: (331) 221-2161 |
News Archive
A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.
Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism. This is the company's first sample to be released and infused for the condition. This release closely coincides with World Autism Awareness Day on the 2nd April, for which Smart Cells have released a simple informational guide on autism for parents.
Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat COVID-19. And while the COVID-19 vaccines represent the best measure to prevent the disease, therapies for those who do get infected remain in short supply.
Diabetes Care published online the results of the Novo Nordisk LEAD™ 6 extension study, which evaluated the efficacy and safety of switching from exenatide, which is taken twice a day, to once-daily Victoza®. Results show that when added to oral antidiabetes drugs, patients who switched from exenatide to Victoza experienced further reductions in A1c and weight loss.
› Verified 7 days ago
Juliet Ibanez Panambo, AGPCNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Po Box 745, Elmhurst, IL 60126 Phone: 630-400-1575 | |
Heather Ann San Juan, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 613 S Poplar Ave, Elmhurst, IL 60126 Phone: 630-217-9620 | |
Kelly Rae Morris, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1200 S York St Ste 2000, Elmhurst, IL 60126 Phone: 331-221-9003 | |
Lina G Patel, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 429 N York Rd, Elmhurst, IL 60126 Phone: 630-782-4050 Fax: 630-782-5021 | |
Judith G Benka, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1200 S York St Ste 2000, Elmhurst, IL 60126 Phone: 331-221-9002 Fax: 331-221-2747 | |
Erin C Daley, DNP, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 155 E Brush Hill Rd, Elmhurst, IL 60126 Phone: 331-221-1000 | |
Izolda Rosario, AGNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 501 W Lake St Ste 207, Elmhurst, IL 60126 Phone: 312-513-9863 |